BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22343687)

  • 1. Procoagulant activity in patients with sickle cell trait.
    Lawrie AS; Pizzey A; Trompeter S; Meiselman H; Mohandas N; Dumanski JP; Westerman MP
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):268-70. PubMed ID: 22343687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
    Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
    Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1 + 2.
    Boisclair MD; Lane DA; Philippou H; Sheikh S; Hunt B
    Thromb Haemost; 1993 Aug; 70(2):253-8. PubMed ID: 8236130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombophilia in sickle cell disease: the red cell connection.
    Setty BN; Rao AK; Stuart MJ
    Blood; 2001 Dec; 98(12):3228-33. PubMed ID: 11719358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm.
    Bailey MA; Griffin KJ; Sohrabi S; Whalley DJ; Johnson AB; Baxter PD; Ariëns RA; Scott DJ
    J Vasc Surg; 2013 Jun; 57(6):1512-8. PubMed ID: 23490299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient.
    Pottier P; Fouassier M; Hardouin JB; Volteau C; Planchon B
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):666-75. PubMed ID: 18796458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activation of hemostasis in patients with chronic cholecystitis].
    Kłoczko J; Lewandowski JJ; Galar M; Mazgajska-Barczyk K; Panek M
    Pol Merkur Lekarski; 2001 Jan; 10(55):19-20. PubMed ID: 11320544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation activation in sickle cell trait: an exploratory study.
    Amin C; Adam S; Mooberry MJ; Kutlar A; Kutlar F; Esserman D; Brittain JE; Ataga KI; Chang JY; Wolberg AS; Key NS
    Br J Haematol; 2015 Nov; 171(4):638-46. PubMed ID: 26511074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAT, F1 + 2, and D-dimer levels in patients after coronary angiography with nonionic or ionic contrast media or after cardiac catheterization.
    Biancardi M; Cimminiello C; Toschi V; Schiavina G; Regalia F; Casolo F; Bonfardeci G
    Semin Thromb Hemost; 1996; 22 Suppl 1():61-5. PubMed ID: 8807731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboelastographic characterization of the activated clotting system in children with sickle cell trait or sickle cell disease.
    Gupta S; Carmona R; Malvar J; Young G
    Thromb Res; 2017 Mar; 151():44-50. PubMed ID: 28110132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
    Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
    Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation changes in individuals with sickle cell trait.
    Westerman MP; Green D; Gilman-Sachs A; Beaman K; Freels S; Boggio L; Allen S; Schlegel R; Williamson P
    Am J Hematol; 2002 Feb; 69(2):89-94. PubMed ID: 11835343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of thrombotic and fibrinolytic factors with severity of culprit lesion in patients with acute coronary syndromes without ST elevation.
    Turker Y; Dogan A; Ozaydin M; Kaya S; Onal S; Akkaya M; Erdogan D
    South Med J; 2010 Apr; 103(4):289-94. PubMed ID: 20224507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
    Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
    Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
    Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
    Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of coagulation activation markers (soluble fibrin polymer, TpP, prothrombin fragment 1.2, thrombin-antithrombin, and D-dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders.
    Arkel YS; Paidas MJ; Ku DH
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):199-205. PubMed ID: 11943933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of F(1+2) prothrombin fragments and thrombin - antithrombin III (TAT) complexes in patients with dermatitis herpetiformis.
    Wankiewicz A; Iwan-Zietek I; Gwieździński Z; Kotschy M
    Med Sci Monit; 2002 Aug; 8(8):BR324-7. PubMed ID: 12165736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.